Skip to content

ResMed RMD Balance Sheet Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
$1.66B+17.2%$1.42B+2.4%$1.38B+14.4%$1.21B+29.7%$932.71M+78.7%
$998.84M+1.3%$985.63M+8.6%$907.27M-3.4%$939.49M+3.5%$907.83M+5.6%
$911.88M-1.1%$922.05M-2.5%$945.81M+2.0%$927.71M+7.5%$862.64M-2.2%
$4.06B+6.4%$3.82B+5.3%$3.63B+3.4%$3.51B+9.3%$3.21B+13.1%
$566.97M+0.5%$564.25M+0.1%$563.63M+2.3%$550.79M+2.9%$535.34M+2.9%
$3.04B0.0%$3.04B0.0%$3.04B-0.1%$3.05B+6.9%$2.85B+1.6%
$425.19M-1.2%$430.24M-3.8%$447.07M-3.8%$464.86M+8.1%$430.11M-1.8%
$4.72B+0.8%$4.68B0.0%$4.68B+0.3%$4.67B+7.1%$4.36B+1.2%
$8.78B+3.3%$8.5B+2.3%$8.31B+1.6%$8.17B+8.0%$7.57B+6.0%
$273.3M+9.1%$250.41M-6.1%$266.78M-4.1%$278.16M+25.0%$222.56M+1.0%
$179.28M+1.8%$176.05M+4.9%$167.78M+1.1%$166.03M+3.5%$160.45M+2.5%
$259.93M0.0%$259.91M0.0%$259.9M+2,525%$9.9M-0.1%$9.91M0.0%
$259.93M0.0%$259.91M0.0%$259.9M+2,525%$9.9M-0.1%$9.91M0.0%
$1.35B+8.3%$1.25B-0.6%$1.26B+23.2%$1.02B+8.4%$940.52M+10.4%
$664.1M0.0%$663.83M-0.7%$668.56M0.0%$668.29M-0.7%$673.03M0.0%
$941.16M+0.7%$934.38M+0.3%$931.59M-21.5%$1.19B+9.9%$1.08B+4.2%
$2.29B+5.0%$2.18B-0.2%$2.19B-0.9%$2.21B+9.2%$2.02B+7.0%
$763K0.0%$763K+0.1%$762K+0.1%$761K0.0%$761K+0.1%
$6.96B+4.7%$6.65B+4.8%$6.34B+4.3%$6.08B+5.2%$5.78B+5.2%
$6.49B+2.7%$6.32B+3.3%$6.12B+2.6%$5.97B+7.6%$5.55B+5.6%
$8.78B+3.3%$8.5B+2.3%$8.31B+1.6%$8.17B+8.0%$7.57B+6.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are ResMed's total assets?
ResMed (RMD) holds $8.8B in total assets, up 16.1% year over year.
How much debt does ResMed have?
ResMed carries $1.1B in total debt against $6.5B of shareholders' equity, a debt-to-equity ratio of 0.17.
How much cash does ResMed have?
ResMed holds $1.7B in cash and equivalents.
Can ResMed cover its short-term obligations?
Its current ratio is 3.01 — current assets exceed current liabilities.
Where does ResMed's balance sheet data come from?
Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.